In this four-part series, Ines Tenente (Senior Consultant – Global Market Access) explores the various challenges facing orphan medicines entering the European market and suggests solutions that can help improve...
Read More
Challenges for orphan medicines entering the European market – Part 3: Economic evidence development
In this four-part series, Ines Tenente (Senior Consultant – Global Market Access) explores the various challenges facing orphan medicines entering the European market and suggests solutions that can help improve patient...
Read More
Challenges for orphan medicines entering the European market – Part 2: Clinical evidence development
In this four-part series, Ines Tenente (Senior Consultant – Global Market Access) explores the various challenges facing orphan medicines entering the European market and suggests solutions that can help improve patient...
Read More
In this four-part series, Ines Tenente (Senior Consultant – Global Market Access) explores the various challenges facing orphan medicines entering the European market and suggests solutions that can help improve...
Read More
Inês M Tenente shares what drives her passion for market access, why she chose to join the Mtech Access Global Market Access team and what she has experienced in the...
Read More